Active substance
Dihydrocodeine
- NHS prices 5
- Safety 1
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Dihydrocodeine 120mg modified-release tablets | £19.71 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dihydrocodeine 30mg tablets | £1.82 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dihydrocodeine 30mg tablets | £6.50 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dihydrocodeine 60mg modified-release tablets | £9.88 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Dihydrocodeine 90mg modified-release tablets | £16.45 | 56 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 22 Dec 2025 SYNALGOS-DC — safety-related labeling change
Labeling sections changed: Boxed Warning; Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.